Cassidy Staffer: TROA On Hold Until CMS AOM Rule Is Decided

By Luke Zarzecki / March 3, 2025 at 7:12 PM
Sen. Bill Cassidy’s (R-LA) office is in discussions with the Trump administration to finalize coverage of anti-obesity medications after the Biden administration proposed a rule that would do so. Legislative movement on the Treat and Reduce Obesity Act (TROA) is paused until the decision is made, but the chances of the introduced version of TROA passing without the CMS rule proceeding remains slim. At play is a proposed CMS rule from the Biden administration that reinterprets status to allow coverage...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.